Studying Tumor-ReacTive T Cells: A Personalized Organoid Model

摘要

Recently inCell, introduced a tumor organoid/lymphocyte co-culture-based approach to expand and analyze tumor-specific T?cell responses in a patient-specific manner. The platform is applicable for epithelial cancers and may have significant value for clinical translation of novel personalized immunotherapies.